Australia’s Clinical Research Advantage
The premier choice for cutting edge clinical trials
Why Australia is the preferred destination for trials
Cost Advantage
- AU is c.60% cheaper for early-stage clinical trials than the US, after tax incentives
- Government offers 43.5% R&D tax credit compared to c.31% in Canada/UK and 7% in US
Globally recognised data
- Clinical data compliant with highest international standards — accepted by US FDA/EMEA
- Positive IP environment — broad patentable subject matter, extended patent terms + 5 years data exclusivity
Streamlined regulatory pathway
- AU Clinical Trial Notification Scheme is global best practice in reducing regulatory requirements and trial lengths
- Trial approval times in AU 5, can be ~3 months vs. 56 months in US
World class people and facilities
- Highly regarded medical research and healthcare system and infrastructure led by some of the world’s leading scientists and physicians
- World class equipment for testing/treatment/analysis
Seasonal advantage
- Northern hemisphere sponsors can conduct trials year-round by taking advantage of Australia’s counter flu and allergy seasons
Ethnically diverse population
- AU demographics are diverse, accessible and aligned to major European and US markets
- Large population born overseas — capability to run trials as on non-Caucasian ethnicities
